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The widespread use of antibiotics plays a major role in the development and spread of anti-
microbial resistance. However, important knowledge gaps still exist regarding the extent of
their use in low- and middle-income countries (LMICs), particularly at the primary care level.
We performed a systematic review and meta-analysis of studies conducted in primary care
in LMICs to estimate the prevalence of antibiotic prescriptions as well as the proportion of
such prescriptions that are inappropriate.
Methods and findings
We searched PubMed, Embase, Global Health, and CENTRAL for articles published
between 1 January 2010 and 4 April 2019 without language restrictions. We subsequently
updated our search on PubMed only to capture publications up to 11 March 2020. Studies
conducted in LMICs (defined as per the World Bank criteria) reporting data on medicine use
in primary care were included. Three reviewers independently screened citations by title
and abstract, whereas the full-text evaluation of all selected records was performed by 2
reviewers, who also conducted data extraction and quality assessment. A modified version
of a tool developed by Hoy and colleagues was utilized to evaluate the risk of bias of each
included study. Meta-analyses using random-effects models were performed to identify the
proportion of patients receiving antibiotics. The WHO Access, Watch, and Reserve
(AWaRe) framework was used to classify prescribed antibiotics. We identified 48 studies
from 27 LMICs, mostly conducted in the public sector and in urban areas, and predominantly
based on medical records abstraction and/or drug prescription audits. The pooled
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prevalence proportion of antibiotic prescribing was 52% (95% CI: 51%–53%), with a predic-
tion interval of 44%–60%. Individual studies’ estimates were consistent across settings.
Only 9 studies assessed rationality, and the proportion of inappropriate prescription among
patients with various conditions ranged from 8% to 100%. Among 16 studies in 15 countries
that reported details on prescribed antibiotics, Access-group antibiotics accounted for more
than 60% of the total in 12 countries. The interpretation of pooled estimates is limited by the
considerable between-study heterogeneity. Also, most of the available studies suffer from
methodological issues and report insufficient details to assess appropriateness of
prescription.
Conclusions
Antibiotics are highly prescribed in primary care across LMICs. Although a subset of studies
reported a high proportion of inappropriate use, the true extent could not be assessed due to
methodological limitations. Yet, our findings highlight the need for urgent action to improve
prescription practices, starting from the integration of WHO treatment recommendations
and the AWaRe classification into national guidelines.
Trial registration
PROSPERO registration number: CRD42019123269.
Author summary
Why was this study done?
• Inappropriate use of antibiotics, both in terms of incorrect regimens and prescription
without clinical indication, is a major driver of antibiotic resistance.
• Global drug sales data indicate a substantial increase in antibiotic use in low- and mid-
dle-income countries (LMICs) over the past 2 decades.
• An accurate quantification of antibiotic prescribing in primary care across LMICs is not
available.
What did the researchers do and find?
• We conducted a systematic review and meta-analysis to estimate the proportion of anti-
biotic prescribing across primary care settings in LMICs.
• Our study showed that, on average, approximately half of patients attending primary
care facilities in LMICs received at least 1 antibiotic.
• Very few included studies made an attempt to assess the extent of inappropriate pre-
scriptions and indicate potential misuse.
• Among studies that provided information on the types of antibiotics used, we found
that, in 12/16 studies, 60% of prescriptions were for antibiotics with low potential for
resistance selection as defined by the World Health Organization (WHO).
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What do these findings mean?
• Our study highlights that antibiotics are highly prescribed in outpatient primary care
settings.
• Better quality data are necessary to dig deeper into the patterns of inappropriate use
according to local epidemiologic scenarios.
• Adapting WHO treatment recommendations and incorporating the WHO Access,
Watch, and Reserve (AWaRe) classification of antibiotics into national guidelines will
be a first key step to improve prescription practices.
Introduction
Antimicrobial resistance (AMR) is a major health threat globally [1]. Growing morbidity and
mortality rates due to resistant infections in humans are expected worldwide, along with a sub-
stantial economic impact in terms of productivity losses and healthcare expenditures [2,3].
Several factors are known to play a role in the development and spread of AMR, with inap-
propriate use of antibiotics being one of its most important drivers [4]. Gathering data about
resistance as well as antibiotic use is 1 of the top 5 priorities of the Global Action Plan on Anti-
microbial Resistance by the World Health Organization (WHO) [5].
A multinational survey conducted across 76 countries to determine the magnitude of anti-
biotic consumption and its trend over time revealed a dramatic increase between 2000 and
2015 (+65% globally), mostly driven by a sharp rise in low- and middle-income countries
(LMICs) (+114%), where the levels of antibiotic consumption are high and rapidly approach-
ing those observed in high-income countries (HICs) [6]. However, this analysis was based on
drug sales data, thus providing limited information regarding providers’ prescription habits.
The high level of antibiotic consumption in LMICs is because of multiple factors, including
the high burden of infectious diseases, lack of regulations (or weak enforcement) to prevent
over-the-counter sale of antibiotics, inadequate training of healthcare professionals, and the
limited availability of essential diagnostics, which favors empirical use of antibiotics [1,7,8].
Besides misuse (i.e., prescription without clinical indication), another huge concern is the
inappropriate use of antibiotics in terms of choice of a suitable molecule, dosage, and duration
of treatment according to the site of infection and patient’s characteristics.
Most studies investigating the magnitude and determinants of antibiotic use have focused
on HICs, and those from LMICs have been carried out predominantly in hospital settings [9–
12], leaving a number of unanswered questions about current practices at the primary health-
care level, where the bulk of antibiotic use takes place.
Of note, there is a paucity of information regarding the degree and pattern of antibiotic use
in outpatient primary healthcare facilities, i.e., any service (other than pharmacies) providing
care for people making an initial contact with a health professional. Having this information
will be helpful to design and implement effective stewardship interventions and policies in
LMICs.
We conducted a systematic review of the literature to assess the extent and patterns of anti-
biotic prescription and their determinants at the primary healthcare level in LMICs, as well as
the proportion of such prescriptions deemed to be inappropriate.
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Methods
The protocol for this systematic review was registered in the International Prospective Register
of Systematic Reviews (PROSPERO) (identifier: CRD42019123269) and followed the PRISMA
guidelines [13]. The PRISMA checklist and PROSPERO protocol are provided as S1 PRISMA
Checklist and S1 PROSPERO Protocol.
Search strategy and selection criteria
We performed a systematic review of cross-sectional studies that were conducted in primary
care in LMICs and reported the proportion of individuals receiving any antibiotic or the pro-
portion of drug prescriptions that included an antibiotic. We also examined randomized and
non-randomized trials as well as other observational studies to determine whether potentially
relevant information (e.g., results from preliminary field assessments including cross-sectional
drug prescription data) was provided. Conference proceedings and abstracts, commentaries,
editorials, reviews, mathematical modeling studies, economic analyses, qualitative studies, and
studies published in predatory journals as defined by Beall [14] were excluded. Studies con-
ducted solely in an inpatient setting, those that focused on veterinary use of antibiotics, and
those that only enrolled patients belonging to special cohorts (e.g., patients with cystic fibrosis
or neutropenia or other underlying conditions that may justify an increased empirical use of
antibiotics, or patients receiving antibiotics as part of prophylactic regimens) were also ineligi-
ble. No restrictions were applied with regards to the population characteristics in terms of age,
sex, pregnancy status, or HIV status.
For the purpose of the study, we considered as “primary care” any care provided by any
health professional (other than pharmacists) with whom patients have their initial contact, in
the public or private sector, including primary care delivered in hospital settings wherever
appropriate. In cases of uncertainty, we contacted the study authors for clarification. Antibiot-
ics were defined as any agents included in the J01 group of the ATC (Anatomical Therapeutic
Chemical) classification system [15]. Inappropriate prescriptions were recorded when such
assessment was performed in the original studies. Countries were classified as low, lower-mid-
dle, upper-middle, or high income following the World Bank categorization based on gross
national income per capita (GNI) of the study start year [16]. GNI thresholds for the definition
of such categories, which have changed slightly over time, are provided in S1 Table. Given that
there is no international standard definition of “urban” and “rural” areas, we classified the
study settings in accordance with the authors’ statements. If not explicitly stated by the investi-
gators, we categorized as “urban” any site with a minimum population of 2,000 inhabitants,
i.e., the most frequently used cutoff [17].
The search strategy was built in collaboration with a medical librarian (GG), using key
terms for “antibiotic,” “primary healthcare,” “prescribing,” and “LMICs” (both as a group and
as individual countries, adopting a filter that was developed according to the World Bank cate-
gories). Medline (PubMed), Embase (Ovid), Global Health (Ovid), and CENTRAL (Cochrane
Library) were systematically searched from 1 January 2010 until 4 April 2019. We also reran
our search on 11 March 2020 using PubMed only; for feasibility reasons, the update could not
be conducted through all data sources used in the initial search. Studies conducted before 1
January 2010 were excluded. The start date of our search was established after the conduction
of an exploratory review of the literature showing that only a small number of studies were
performed before 2010 in relevant settings, in the face of the exponentially higher number of
total records identified through our search strategy, which would have posed substantial feasi-
bility issues with very little benefit. Additionally, as patterns of antibiotic prescribing have
changed substantially over time, including older studies would have been of limited value for
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understanding the current situation. No language restrictions were applied. The full search
strategies for each database are presented in S1 Text.
Study screening and data extraction
Search results were imported into a citation manager (EndNote X9, Clarivate Analytics), and
duplicates were removed. Three authors (GS, PA, and VN) independently screened citations
by title and abstract against predefined eligibility criteria. The full-text review of all selected
records was performed by 2 authors (GS and PA). An electronic data extraction form was
piloted on 5 randomly selected papers and then used by 2 reviewers (GS and PA) to extract
information from all eligible publications. At each stage of the screening and data extraction
process, disagreements were resolved through discussion, and, if necessary, a third author
(SG) was consulted to reach consensus. Study authors were contacted to request clarifications
or additional data if needed. A detailed description of the screening and data extraction pro-
cess is provided in S2 Text along with interrater agreement statistics.
Assessment of study quality and publication bias
A modified version of a tool developed by Hoy and colleagues was utilized to evaluate the risk
of bias of each included study (S2 Table) [18]. Our checklist included 8 methodological items
(rated as low or high risk of bias), plus a summary item on the overall risk of study bias (rated
as low, moderate, or high); no numeric scores were applied. All findings from this assessment
were recorded in the data extraction form by the same independent reviewers. As a sensitivity
analysis, we excluded studies with a high overall risk of bias.
No formal assessment of publication bias could be performed since traditional approaches
such as funnel plots and tests for asymmetry are considered unsuitable for prevalence studies
[19].
Statistical analysis
Depending on the type of data available from individual studies, we calculated either the pro-
portion of patients evaluated in a given health facility or by a certain provider who received
antibiotics or the proportion of all drug prescriptions containing any antibiotics, along with
their Clopper–Pearson (or exact) 95% confidence intervals (CIs) [20]. The 2019 WHO Access,
Watch, and Reserve (AWaRe) framework was used to classify antibiotics according to their
potential for selecting resistance [21]. Access-group antibiotics are first-line and narrow-
spectrum agents such as penicillin, amoxicillin, and trimethoprim-sulfamethoxazole.
Watch-group antibiotics are broad-spectrum agents with higher resistance selection such as
second- and third-generation cephalosporins, and fluoroquinolones. Reserve-group antibiot-
ics include last-resort antibiotics such as colistin. Fixed-dose combinations of antibiotics (e.g.,
ciprofloxacin/ornidazole) were classified as “discouraged” antibiotics, in line with WHO
recommendations.
Random-effects meta-analyses were performed to estimate pooled proportions after Free-
man–Tukey transformation to normalize the outcome [22]. To assess the between-study het-
erogeneity, we used the I2 statistic and calculated prediction intervals (i.e., a type of confidence
interval that provides the 95% range of true values to be expected in similar studies) [23,24].
Random-effects meta-regression with Knapp–Hartung adjustment (aimed to accommodate
high degrees of heterogeneity) was employed to investigate the sources of heterogeneity. Cate-
gorical predictors for facility location (urban/rural), healthcare sector (public/private), age
group (adults/children/all), type of patients (i.e., patients seeking care for any reason or indi-
viduals with a specific condition, e.g., diarrhea), and source of prescription information were
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considered for building the model. If collinearity issues were observed, variables with the low-
est number of missing values were prioritized and included in the model.
Subgroup analyses were conducted to investigate potential differences across levels of coun-
try income and types of patients involved (with a focus on studies where all patients attending
1 or more facilities were considered without placing restrictions based on their clinical
presentation).
Sensitivity analyses were done by repeating analyses without studies that (i) were conducted
in Iran as they were all based on administrative data from national registers; (ii) did not report
details on the population and/or health facility location; (iii) were conducted in low-income
countries; (iv) were based on the standardized patient methodology, in which antibiotics were
deemed inappropriate by indication; (v) were deemed to be low quality (i.e., overall risk of
study bias scored as “high”).
All analyses were conducted in Stata (version 14; StataCorp) [25,26].
Results
Our initial search yielded 9,604 unique citations, and an additional 590 were retrieved through
our search update. A total of 48 studies (all cross-sectional) were finally included in the analy-
ses (Fig 1) [27–74]. All included publications were in English language, except for 1 that was in
Spanish. A summary of the main study characteristics is presented in Table 1, and the full data-
set used for analyses is provided as S1 Data. Most studies were conducted in lower-middle- or
upper-middle-income countries (22 and 19, respectively), while only 6 were in a low-income
country. Additionally, 1 study was carried out in 3 countries (1 low income and 2 lower-mid-
dle income) [70]. Both public and private healthcare services were involved in 10 of the 48
(20.8%) included studies, whereas 26 (54.2%) studies were focused on the public sector, 4
(8.3%) were focused on the private sector, and 8 (16.7%) did not provide this information;
none of the studies mentioned any involvement of informal practitioners. Facilities located in
urban areas were more represented than those located in rural areas (17/48 studies [35.4%;
95% CI: 22.2%–50.5%] versus 10/48 studies [20.8%; 95% CI: 10.5%–35.0%]), with 13 (27.1%)
studies involving both settings and 8 (16.7%) not reporting sufficient details. While 9 (18.8%)
studies only included individuals presenting with 1 prespecified condition (i.e., acute respira-
tory illness, diarrhea, or fever), the other studies did not apply restrictions on the reason for
seeking care and/or the final diagnosis (if any) and likely included patients with various condi-
tions. None of the studies focused solely on dental care; although it is possible that patients
seeking dental care were included in some studies, this group likely represented a negligible
proportion of the total sample. Of note, no clinical information was reported in most studies.
Importantly, almost all the studies identified through our systematic review only assessed
drug prescription and did not account for direct dispensing of unlabeled medicines, which is
likely a common practice [75]. This may underestimate the true antibiotic prescribing
proportion.
Study quality
Fig 2 displays the summary of the risk of bias assessment, while the individual studies’ quality
assessment results are presented in S3 Table. The overall risk of study bias was scored as high
for 21/48 studies (43.8%), moderate for 11 (22.9%), and low for 16 (33.3%). The proportion of
studies assigned to the high risk group was higher among those conducted in low- and lower-
middle-income countries (14/28; 50%) and lower among those performed in upper-middle-
income countries (7/19; 36.8%). No major changes were observed in terms of overall study
quality over time, although this could be due to the limited number of studies. In general, the
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biggest issues were observed with regards to external validity: Some form of random sampling
or a census was seldom performed, and the study population was rarely representative of the
target, mostly due to the fact that prescriptions were often selected from one or a few facilities
in circumscribed areas. The case definition was considered inadequate for studies that did not
record clinical details about patients receiving prescriptions. The risk of bias concerning the
data collection method was deemed to be low for studies that used medical records or similar
sources to retrieve prescription information. This choice was made based on the fact that
Fig 1. PRISMA diagram.
https://doi.org/10.1371/journal.pmed.1003139.g001
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Data source Age group Denominator�
Low Baltzell 2019 [68] Malawi Private Rural NA Medical records NA 9,924 (P)
Mukonzo 2013 [27] Uganda Both Both 1 Medical records, prescription
audit
All 173 (P)
Nepal 2020 [73] Nepal Public Urban NA Prescription audit All 950 (P)
Savadogo 2014 [28] Burkina Faso Public Urban 2 Medical records Children 376 (P)
Worku 2018 [29] Ethiopia Public Urban 6 Medical records, prescription
audit
All 898 (D)
Yebyo 2016 [30] Ethiopia Public Rural 4 Medical records Adults 414 (P)
Lower-
middle
Abdulah 2019 [31] Indonesia Public NA 25 Prescription audit Adults 10,118 (D)
Adisa 2015 [32] Nigeria Public Urban 8 Prescription audit Adults 400 (P)
Ahiabu 2016 [33] Ghana Both Both 4 Medical records All 1,600 (D)
Akl 2014 [34] Egypt Public Urban 10 Medical records NA 1,000 (D)
Atif 2016 [35] Pakistan NA Urban 10 Prescription audit NA 1,000 (D)
Beri 2013 [36] India Private Urban 20§ Provider interview All 400 (P)
Chem 2018 [37] Cameroon Both Both 26 Medical records All 30,096 (D)
El Mahalli 2011 [38] Egypt Public Urban 2 Medical records Children 300 (P)
Graham 2016 [39] Zambia NA NA 90§ Provider interview Children 537 (P)
Jose 2016 [40] India Public Rural 1 Prescription audit Children 552 (D)
Kasabi 2015 [41] India Public NA 20 Medical records NA 600 (P)
Mekuria 2019 [72] Kenya Private Urban 4 Prescription audit All 17,382 (P)
Ndhlovu 2015 [42] Zambia Both Both 148 Patient interview, medical
records
All 872 (P)
Omole 2018 [43] Nigeria Both Rural NA Prescription audit NA 4,255 (D)
Oyeyemi 2013 [44] Nigeria Public Urban 4 Medical records All 600 (D)
Raza 2014 [45] Pakistan Both Urban NA Prescription audit NA 1,097 (D)
Sarwar 2018 [46] Pakistan Public Both 32 Prescription audit NA 6,400 (D)
Saurabh 2011 [47] India NA Rural 4 Prescription audit NA 600 (D)
Saweri 2017 [48] PNG Public Both 7 Ad hoc form All 6,008 (P)
Sudarsan 2016 [49] India Public Urban 1 Prescription audit NA 360 (D)
Yousif 2016 [50] Sudan Both NA 220§ Prescription audit NA 19,690 (D)
Yuniar 2017 [51] Indonesia Both NA 56 Prescription audit NA 1,657 (D)
Upper-
middle
Ahmadi 2017 [52] Iran Public Rural 103 Prescription audit NA 352,399 (D)
Alabid 2014 [53] Malaysia Private Urban 70 Patient interview Adults 140 (P)
Bielsa-Fernandez 2016
[54]
Mexico NA Urban 109§ Provider interview All 1,840 (P)
Gasson 2018 [55] South Africa Public Urban 8 Medical records All 654 (P)
Greer 2018 [56] Thailand Public Both 32 Medical records All 83,661 (P)
Lima 2017 [57] Brazil NA NA 20 Prescription audit NA 399 (D)
Liu 2019 [71] China Public Both 65 Prescription audit All 428,475 (D)
Mashalla 2017 [58] Botswana Public Urban 19 Prescription audit All 550 (D)
Ab Rahman 2016 [59] Malaysia Both Both 545 Medical records All 27,587 (P)
Sadeghian 2013 [60] Iran NA NA NA Prescription audit NA 4,940,767 (D)
Safaeian 2015 [61] Iran NA Both 3,772§ Prescription audit NA 7,439,709 (D)
Sánchez Choez 2018
[62]
Ecuador Public Both 1 Prescription audit All 1,393 (P)
Sun 2015 [63] China Public Both 24 Prescription audit All 1,468 (D)
Wang 2014 [64] China Public Both 48 Medical records All 7,311 (D)
Xue 2019 [65] China Public Rural NA SP exit interview All 526 (P)
Yin 2015 [66] China Both Urban 2,501 Prescription audit NA 42,200 (D)
Yin 2019 [74] China Public Rural 8 Prescription audit All 14,526 (D)
Zhan 2019 [69] China Public Rural 17 Prescription audit All 1,720 (D)
Zhang 2017 [67] China Public Rural 20 Prescription audit Children 9,340 (D)
(Continued)
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medical records and drug prescription audits constitute good sources to estimate the propor-
tion of antibiotic prescribing, although they are generally poorly suited for an accurate evalua-
tion of appropriateness of prescription. On the other hand, studies using patient or provider
questionnaires were considered at high risk of bias given the potential for recall bias and Haw-
thorne effect [76,77].
Prevalence of antibiotic prescription
Among the 21 studies that reported the total number of patients attending a certain facility at
the time of data collection [27,28,30,32,36,38,39,41,42,48,53–56,59,62,65,68,70,72,73], the aver-
age proportion of individuals receiving an antibiotic prescription ranged widely, from 19.6%
(95% CI: 14.0%–26.4%) to 90.8% (95% CI: 89.3%–92.0%) [27,54]. Among the 27 studies in
which the denominator was the total number of drug prescriptions [29,31,33–35,37,40,43–










Data source Age group Denominator�
Multiple Kjærgaard 2019 [70] Kyrgyzstan, Uganda,
Vietnam
NA NA NA Medical records, provider
interview
Children 699 (P)
�Denominator used to calculate the outcome (i.e., total number of patients evaluated [P] or total number of drug prescriptions [D]).
§Number of healthcare providers involved.
NA, not available; PNG, Papua New Guinea; SP, standardized patient.
https://doi.org/10.1371/journal.pmed.1003139.t001
Fig 2. Summary of study risk of bias assessment.
https://doi.org/10.1371/journal.pmed.1003139.g002
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antibiotics varied between 17.8% (95% CI: 14.2%–21.9%) and 79.2% (95% CI: 74.4%–82.7%)
[46,57]. We could not identify any specific pattern in the distribution of antibiotic prescription
rates across levels of country income, partly due to small sample sizes. As very few studies were
conducted solely in the private health sector, no comparisons could be made against public
facilities. Similar considerations apply to the health service location (i.e., urban versus rural
areas). Furthermore, we did not observe any specific variation over time in the proportion of
patients receiving antibiotics, either overall or after stratifying by country income level.
Since almost all patient–provider encounters included in studies using patients as the
denominator resulted in a treatment prescription, prevalence estimates can be considered
comparable to those derived from the 27 studies using drug prescriptions as the denominator.
The pooled proportion of patients who received antibiotics resulting from a meta-analysis of
all studies was 52% (95% CI: 51%–53%), and both stratum-specific pooled proportions for
studies using one or the other type of denominator were reasonably close to the overall esti-
mate (Fig 3). As expected, very high levels of between-study heterogeneity were observed (I2
values were above 98% overall, in subgroup analyses, and in sensitivity analyses), thus limiting
the reliability of our pooled estimates. However, the 95% prediction interval calculated in the
primary analysis was quite narrow, ranging from 44% to 60%, indicating that a new potential
observation in a similar setting would likely yield a proportion of patients receiving antibiotics
close to 50%. The prediction interval is wider than the conventional confidence interval owing
to the fact that it accounts for uncertainty about both the population mean and the distribution
of values.
Subgroup analyses (e.g., after stratification by country income level, type of denominator,
or type of patients examined) and sensitivity analyses yielded similar point estimates, but con-
fidence and prediction intervals became much wider (S1–S4 Figs). Unsurprisingly, given the
results of subgroup meta-analyses, none of the coefficients of our meta-regression models was
statistically significant, and the overall model could only explain a negligible proportion of the
observed heterogeneity (S4 Table).
Inappropriate antibiotic prescription
As previously mentioned, we recorded the proportion of inappropriate prescriptions when
available in individual studies. In most cases, the authors made their judgment based on
national and/or international guidelines for treatment of key conditions. Among the 9 studies
that assessed the rationality of antibiotic prescriptions [36,39,46,53,55,62,64,65,67], the propor-
tion judged inappropriate ranged widely, reflecting the significant differences in study designs
as well as in the sets of criteria that were adopted to determine the outcome (Table 2). The low-
est level of inappropriate prescription (7.9%; 95% CI: 4.6%–12.5%) was reported in a study
conducted in Zambia that included 537 children aged<5 years presenting with an acute respi-
ratory syndrome, of whom 37.6% (95% CI: 33.5%–41.9%) were given antibiotics [39]. All anti-
biotic prescriptions were classified as inappropriate in 3 studies: 2 of them employed
standardized patients portraying conditions that did not require antibiotics such as common
cold, watery diarrhea, presumptive tuberculosis, and chest pain indicative of angina, with an
overall antibiotic prescription prevalence of about 41%–42% [53,65]; the other study was per-
formed in China and included 9,340 drug prescriptions issued for children with acute respira-
tory tract infection of likely viral etiology, 36.6% (95% CI: 35.7%–37.6%) of whom received an
antibiotic [67]. The proportion of inappropriate antibiotic prescriptions exceeded 50% in the
remaining 5 studies.
Information regarding individual antibiotics was available from 16 studies in 15 countries.
Of note, 11 of these studies included patients seeking care for any reason, while the remaining
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5 studies focused on a specific condition (i.e., respiratory tract infection [4 studies] or diarrhea
[1 study]) (Table 3). Access-group antibiotics accounted for the majority of prescriptions
(more than 60%) in 13 studies from 12 countries, whereas Watch-group antibiotics accounted
Fig 3. Forest plot of antibiotic prescription prevalence across all studies stratified by type of denominator used (i.e., either total number of patients or total number
of drug prescriptions). CI, confidence interval; ES, effect size; PNG, Papua New Guinea.
https://doi.org/10.1371/journal.pmed.1003139.g003
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for high proportions of prescriptions among studies from Mexico (90.3%; 95% CI: 88.8%–
91.7%), China (78.4%; 95% CI: 75.7%–81.0%), and Pakistan (47.8%; 95% CI: 46.5%–49.1%)
(Table 3) [46,54,63].
Discussion
To our knowledge, this is the first comprehensive analysis of antibiotic prescriptions in pri-
mary care in LMICs. We found that the proportion of patients seeking care for any reason
who were prescribed antibiotics in this context often exceeded 50%. Although the interpreta-
tion of our pooled estimates is limited by the considerable between-study heterogeneity, values
were quite consistent across settings. Available studies from LMICs often suffer from several
methodological issues and report scanty details concerning patients’ clinical features that
would help accurately judge the appropriateness of prescription. The number of health facili-
ties involved in individual studies is often very small, particularly in low-income countries (a
total of 13 facilities across 4 studies that reported this information), indicating major discrep-
ancies in the quality of information among geographic areas. Although all included studies
examined prescription data in primary care facilities, we recognize that primary care entails a
wide range of facility types, each with its own peculiarities and challenges. This variegated sce-
nario prevented us from conducting specific subgroup analyses that could inform targeted
antibiotic stewardship strategies. Two studies, both conducted in an Iranian province, had a
very large sample size because prescription details were captured through an electronic data
collection system that is available nationwide. However, clinical information on patients
receiving each prescription is much more challenging to obtain from this system, thus hinder-
ing a thorough assessment of inappropriate drug use.
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Public 526 Adult and child SPs with 1 of the following:
diarrhea (viral gastroenteritis), chest pain
(suspicious for angina), fever and cough
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Public 9,340 Children with upper respiratory tract infection 3,425 (36.7; 35.7–
37.7)
3,425 (100)
CI, confidence interval; SP, standardized patient; TB, tuberculosis.
https://doi.org/10.1371/journal.pmed.1003139.t002
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WHO recommends that the proportion of patients receiving antibiotics in an outpatient
setting should be less than 30% [78]. However, this threshold was established somewhat arbi-
trarily more than 2 decades ago, due to a lack of evidence on prescription practices and actual
needs according to patients’ clinical features. If accurate and nationally representative pre-
scribing data were available for individual countries, these could be used as a benchmark to
define condition-specific ideal prescribing proportions that account for context-related
variables.
High infectious disease burden in LMICs could potentially explain the high prevalence of
antibiotic use; however, our results raise concerns about potential misuse of antibiotics based
on a subset of studies that assessed the rationality of antibiotic prescriptions. For example,
high levels of antibiotic prescriptions (41%–42%) were reported in 2 standardized patient stud-
ies in Malaysia and China, where nobody should have received antibiotics, by design [53,65].
In a study conducted in Mexico, 69% of patients had had watery diarrhea for less than 48
hours, but almost everybody received antibiotics instead of rehydration alone [54]. Similarly,
in a nationwide health facility survey in Zambia, 72.2% of patients met the criteria for sus-
pected malaria, for which antibiotics are not appropriate treatment, but nonetheless more than
half were given antibiotics [42]. Studies focused on individuals with upper respiratory symp-
toms such as common cold or pharyngitis reported unacceptably high antibiotic prescribing
proportions, ranging from 36.7% to 55.3% [39,62,63,67].
Table 3. AWaRe classification of antibiotic prescriptions in a subset of studies included in analysis.
Study, total number (n) of











Abdulah (2019) [31], n = 2,389 Indonesia Any 1,667 (69.8) 287 (12.0) NA NA
Sarwar (2018) [46], n = 5,853 Pakistan Any 3,055 (52.2) 2,798 (47.8) 0 0
Sánchez Choez (2018) [62], n = 553 Ecuador Acute respiratory
syndrome
463 (83.7) 90 (16.3) 0 0
Worku (2018) [29], n = 553 Ethiopia Any 431 (77.9) 122 (22.1) 0 0
Gasson (2018) [55], n = 519 South
Africa
Any 361 (69.6) 158 (30.4) 0 0
Chem (2018) [37], n = 12,350 Cameroon Any 11,109 (90.0) 1,241 (10.0) 0 0
Mashalla (2017) [58], n = 289 Botswana Any 240 (83.0) 49 (17.0) 0 0
Ab Rahman (2016) [59], n = 6,009 Malaysia Any 3,879 (64.6) 2,073 (34.5) NA NA
Adisa (2015) [32], n = 303 Nigeria Any 224 (73.9) 61 (20.1) 0 18 (5.9)
Yebyo (2016) [30], n = 373 Ethiopia Acute respiratory
syndrome
312 (83.6) 61 (16.4) 0 0
Ndhlovu (2015) [42], n = 561 Zambia Any 490 (87.3) 42 (7.5) 0 0
Sun (2015) [63], n = 978 China Acute respiratory
syndrome
174 (17.8) 767 (78.4) NA NA
Bielsa-Fernandez (2016) [54],
n = 1,718
Mexico Diarrhea 166 (9.7) 1,551 (90.3) 1 (0.06) 0
Mukonzo (2013) [27], n = 9,683 Uganda Any 7,735 (79.9) 1,908 (19.7) NA NA
Nepal (2020) [73], n = 479 Nepal Any 299 (62.4) 165 (34.4) NA NA
Mekuria (2019) [72], n = 13,646 Kenya Acute respiratory
syndrome
8,461 (62.0) 4,880 (35.7) NA 278 (2.0)
Denominator for percentage calculations is the total number of antibiotics dispensed/prescribed. Access-group antibiotics are first-line and narrow-spectrum agents
such as penicillin, amoxicillin, and trimethoprim-sulfamethoxazole. Watch-group antibiotics are broad-spectrum agents with higher resistance selection such as second-
and third-generation cephalosporins, and fluoroquinolones. Reserve-group antibiotics include last-resort antibiotics such as colistin. Discouraged antibiotics are fixed-
dose combinations such as ciprofloxacin/ornidazole.
NA, not available.
https://doi.org/10.1371/journal.pmed.1003139.t003
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To promote the optimal use of antibiotics and assist antibiotic stewardship efforts, WHO
introduced the AWaRe classification in 2017 [21]. The classification underlines that, where
appropriate, narrow-spectrum antibiotics included in the Access group should be preferred
over broad-spectrum antibiotics from Watch and Reserve groups in order to limit the selection
and spread of antibiotic resistance. Accordingly, WHO recommends that Access-group antibi-
otics should constitute at least 60% of overall antibiotic use [21]. Only 16 of the 48 studies iden-
tified through our systematic review reported detailed information on individual antibiotic
drugs, and all but 3 had at least 60% of antibiotics being from the Access group [21]. Three
studies with a high proportion of Watch-group antibiotics were from Mexico, China, and
Pakistan; however, we cannot generalize these estimates to overall antibiotic consumption in
these countries based on only 1 study in each country. Interestingly, a recent study that ana-
lyzed pediatric antibiotic sales data using AWaRe categories in 70 countries showed a high
proportion of Watch-group antibiotics in China, Pakistan, and Mexico [79].
A recently published umbrella review on antibiotic use for adults in primary care (though
focused on dental care) identified several factors that appear to affect prescribing behaviors in
HICs, such as socio-cultural context, financial incentives, personal beliefs, patients’ attitudes,
and AMR awareness [80]. Similar considerations likely apply to prescription practices in
LMICs, although a deeper understanding of underlying determinants remains challenging.
Among the biggest issues is the poor documentation of clinical reasons leading to antibiotic
prescription, as observed in other settings [81]. Reaching a definitive diagnosis is often a huge
challenge in resource-constrained areas, where point-of-care diagnostic tests for the most
common conditions observed in primary care are frequently lacking [82].
Along with potential antibiotic misuse, therapeutic schemes may be inappropriate because
of inadequate choice of antibiotic or incorrect dose or duration. However, a thorough assess-
ment of prescription practices that includes such considerations is made particularly difficult
by the variability in national treatment guidelines regarding antibiotic regimens [83]. In an
attempt to foster the harmonization of such guidelines and minimize differences across coun-
tries, WHO recently released antibiotic treatment guidelines for 26 common infectious syn-
dromes encountered in primary care and inpatient settings [84]. These guidelines currently
indicate when and what antibiotics should be prescribed, and further work on harmonizing
dose, duration, and formulation is ongoing [21].
In summary, the pooled estimate of antibiotic prescription in primary care settings across
LMICs was 52%, but there was significant between-study heterogeneity. Further, the true
extent of misuse was hard to discern, given the lack of data on appropriateness and the low
quality of studies included. Future studies should use methodologies such as standardized
patients, where the diagnosis is fixed by design, or include thorough laboratory testing to
match diagnoses with antibiotic use. Accurate prescription audit tools are difficult to imple-
ment in most LMICs owing to the limited availability of electronic records. Also, the paucity
of clinical details that can be captured through medical records (paper-based or not) makes it
even harder to determine the appropriateness of prescription [85].
There is a need for better quality data to accurately measure the magnitude of antibiotic
prescribing and dispensing by healthcare professionals at the primary care level accounting for
local epidemiologic patterns. Global burden of disease data [86] combined with nationally rep-
resentative AMR surveillance data [87] could be utilized to estimate the amount and type of
antibiotics needed in a country, which could then be compared with existing national antibi-
otic consumption databases [6]. Meanwhile, LMICs should adapt the WHO infection treat-
ment guidelines and incorporate the AWaRe categorization into their national antibiotic
treatment guidelines to improve antibiotic prescribing. This will help countries to prioritize
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surveillance and stewardship efforts aimed at curbing the spread of AMR and preserving the
efficacy of currently available antibiotics.
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